Genetic testing for advanced nonsmall cell lung cancer (NSCLC) includes EGFR, ALK, ROS1, BRAF, MET, HER-2, RET, NTRK1/2/3, PI3K, and PD-L1. This evidence concerns the gene ALK and non-small cell lung carcinoma.